Public, private partners in a brave new world
By North Jersey Media Group,
North Jersey Media Group
| 06. 22. 2005
There's a lot riding on the promise of biotechnology.
State officials say investing in the emerging medical science will improve New Jersey's balance sheet.
Scientists tout stem cells and other biotech research as the foundation of a whole new world of medicine, a world where the lame could walk and the old could live without debilitation.
For the sick and their loved ones, there is hope where there was none.
During the preparation of this series, The Record heard from dozens of national experts in medicine, science, commerce and government. There was plenty of divergence in their opinions.
But when asked to take the big view, almost all saw a role for both government and the private sector in the quest to turn the promise of biotech into the reality of better health.
Collectively, they offer a few simple guideposts that citizens and their elected representatives might consider when trying to assess how well the partnership is going.
Be patient
Abraham Abuchowski is a former Rutgers scientist who co-founded the New Jersey-based biotech Enzon in the 1980s. He now runs...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...